Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_assertion type Assertion NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_head.
- NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_assertion description "[Thirty-five of 49 (71.4 percent) serrated adenomas exhibited moderate to intense cyclooxygenase-2 immunoreactivity, and 8 of 25 hyperplastic polyps (32 percent) showed weak to moderate cyclooxygenase-2 immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_provenance.
- NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_assertion evidence source_evidence_literature NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_provenance.
- NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_assertion SIO_000772 11584208 NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_provenance.
- NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_assertion wasDerivedFrom befree-20150227 NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_provenance.
- NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_assertion wasGeneratedBy ECO_0000203 NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_provenance.